101 related articles for article (PubMed ID: 11780703)
21. [Adjuvant treatment of head and neck cancers: advances and challenges].
Bernier J
Bull Cancer; 2007 Sep; 94(9):823-7. PubMed ID: 17878103
[TBL] [Abstract][Full Text] [Related]
22. [Primary chemotherapy combining vincristine, bleomycin, methotrexate and cisplatin systemically or intra-arterially in cancers of the upper respiratory and digestive tracts].
Demard F; Schneider M; Vallicioni J; Chauvel P; Lesbats G
Ann Otolaryngol Chir Cervicofac; 1983; 100(8):567-75. PubMed ID: 6200054
[TBL] [Abstract][Full Text] [Related]
23. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
24. Managing early-stage breast cancer in your older patients.
Witherby SM; Muss HB
Oncology (Williston Park); 2006 Aug; 20(9):1003-12; discussion 1012-3, 1017-8. PubMed ID: 16986347
[TBL] [Abstract][Full Text] [Related]
25. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer.
Sejpal S; Komaki R; Tsao A; Chang JY; Liao Z; Wei X; Allen PK; Lu C; Gillin M; Cox JD
Cancer; 2011 Jul; 117(13):3004-13. PubMed ID: 21264827
[TBL] [Abstract][Full Text] [Related]
26. The potential influence of cell protectors for dose escalation in cancer therapy: an analysis of amifostine.
McCumber LM
Med Dosim; 2004; 29(2):139-43. PubMed ID: 15191764
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncology Group.
Leong T; Joon DL; Willis D; Jayamoham J; Spry N; Harvey J; Di Iulio J; Milner A; Mann GB; Michael M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):690-5. PubMed ID: 20472363
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based organ-sparing radiotherapy in head and neck cancer.
Dirix P; Nuyts S
Lancet Oncol; 2010 Jan; 11(1):85-91. PubMed ID: 20129131
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy of carcinoma of the upper respiratory and digestive tract].
Cachin Y; Domenge C
Rev Laryngol Otol Rhinol (Bord); 1986; 107(1):5-7. PubMed ID: 3715237
[No Abstract] [Full Text] [Related]
31. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
32. Current state-of-the-art for concurrent chemoradiation.
Bernier J
Semin Radiat Oncol; 2009 Jan; 19(1):3-10. PubMed ID: 19028339
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.
Macarulla T; Casado E; Ramos FJ; Valverde C; Tabernero J
Onkologie; 2006 Mar; 29(3):99-105. PubMed ID: 16514271
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
Domenge C; Richard JM
Ann Otolaryngol Chir Cervicofac; 1984; 101(2):119-21. PubMed ID: 6372615
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
Norton L
Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
[TBL] [Abstract][Full Text] [Related]
36. [Combination of cisplatin with 5-fluorouracil in the primary treatment of advanced carcinoma of the upper respiratory and digestive tract].
Joveniaux A; Caty A; Adenis L
Bull Cancer; 1984; 71(4):390. PubMed ID: 6541953
[No Abstract] [Full Text] [Related]
37. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
38. Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience.
Dogan NU; Yavas G; Yavas C; Ata O; Yılmaz SA; Celik C
Arch Gynecol Obstet; 2013 Oct; 288(4):845-50. PubMed ID: 23553195
[TBL] [Abstract][Full Text] [Related]
39. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials.
Hallqvist A; Bergman B; Nyman J
Radiother Oncol; 2012 Jul; 104(1):39-44. PubMed ID: 22727262
[TBL] [Abstract][Full Text] [Related]
40. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
